Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
24.46
-0.38 (-1.53%)
Oct 6, 2025, 10:26 AM EDT - Market open
Pacira BioSciences Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$32.40
Upside
+32.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $32 → $30 | Strong Buy | Maintains | $32 → $30 | +22.65% | May 9, 2025 |
| Needham | Needham | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +30.83% | Apr 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $65 | Strong Buy | Maintains | $48 → $65 | +165.74% | Apr 8, 2025 |
| Barclays | Barclays | Buy Maintains $17 → $24 | Buy | Maintains | $17 → $24 | -1.88% | Feb 28, 2025 |
| Needham | Needham | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +30.83% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $70 | Strong Buy | Maintains | $57 → $70 | +186.18% | Feb 28, 2025 |
| Truist Securities | Truist Securities | Strong Sell → Hold Upgrades $8 → $25 | Strong Sell → Hold | Upgrades | $8 → $25 | +2.21% | Jan 30, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $18 | Hold | Reiterates | $18 | -26.41% | Jan 14, 2025 |
| Needham | Needham | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +22.65% | Jan 13, 2025 |
| Needham | Needham | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +22.65% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $39 | Strong Buy | Reiterates | $39 | +59.44% | Dec 4, 2024 |
| Barclays | Barclays | Hold Maintains $25 → $17 | Hold | Maintains | $25 → $17 | -30.50% | Nov 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | -10.06% | Nov 8, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | -34.59% | Nov 7, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $14 → $15 | Hold | Maintains | $14 → $15 | -38.68% | Oct 4, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | -26.41% | Sep 24, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.